analysis of interleukin 12
DESCRIPTION
Analysis of Interleukin 12. Bioinformaticians: Wednesday Sok Joshua Corey Harbindar Singh Mandeep Singh Protein Project February 1, 2002. Interleukin 12. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/1.jpg)
Analysis of Interleukin 12
Bioinformaticians:Wednesday SokJoshua Corey
Harbindar SinghMandeep Singh
Protein ProjectFebruary 1, 2002
![Page 2: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/2.jpg)
Interleukin 12
Interleukin 12, aka IL 12 is only one of many Interleukins present in the body. It is a more recent IL to be studied, therefore there is less information known on the protein. The newer information however could help us better understand ourselves and to find treatment for some genetic diseases.
![Page 3: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/3.jpg)
Background of IL 12 It is a cytokine, a hormone-like substance that regulates
the activity of cells involved in an immune response. IL 12 is one of many naturally produced biological
response modifiers (BRMs). It was first discovered in the late 1980s. By 1991, two genes necessary for IL 12 production were
identified and cloned. IL 12 is made by a select group of immune cells that
normally are the first to encounter disease- causing organisms in the body and react to them.
![Page 4: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/4.jpg)
Known activities Activates other immune cells called T cells, B cells,
dendritic cells and natural killer cells promotes antibiody production by B cells and stimulates
dendritic cells to multiply shown to inhibit angiogenesis, the development of new
blood vessles within tumors immune cells seek and destroy antigens (cancer, tumor
cells), IL 12 increases the production by these cells of interferon gamma, another BRM which augments the killing ability of immune cells
![Page 5: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/5.jpg)
IL 12 instead of IL 2 By activating specific immune cells early in
development of an anti-cancer immune response, IL 12 is associated with less toxicity than IL 2, which is a BRM used in clinical trials for advanced cancer in the last 10 years.
IL 2 is normally released by T cells late in development of an immune response. IL 2 stimulates a strong and immediate immune response which is associated with side effects when administered to patients.
![Page 6: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/6.jpg)
Recent Research in Laboratory Suggests IL 12 can effectively treat a wide
variety of cancers with minimal toxicity. Investigations at Univ. of Pittsburg Cancer
Institute (UPCI) and several other sites around the country now are exploring the use of IL 12 in clinical trials for patients with advanced cancer.
IL 12 effectively eliminates cancer in lab animals that are given small doses of the substance.
![Page 7: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/7.jpg)
Laboratory Results
Mice having advanced cancer eradicated with IL 12 don’t develop the same cancer again if they are artificially re-introduced into the body, which suggests their bodies have developed an immune memory of the cancers.
![Page 8: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/8.jpg)
UPCI Developed 2 protocols Protocol 1 IL 12 protein is injected
into patients with advanced cancer; study accrued patients with different cancers, administered IL 12 in various doses to assess safety and max. tolerated dose of drug, in order to explore the IL 12 ability to fight cancer
Protocol 2 Another clinical trial began
Aug 1995 involving the IL 12 gene transfer to patients with advanced cancer, to allow continuous production of cytokines inside the body. The IL 12 gene delivery system developed by investigators at the UPGenetics Inst is being produced at the UP Biotechoogy Center.
![Page 9: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/9.jpg)
Structure Similarity of IL 12 to IL 6 Protein made up of 3 alpha chains, beta sheets,
and a side chain, the functional unit IL 12 contains an immunoglobulin C-2 type
domain and fibronectin type III domain( on beta) IL 12 is produced and secreted hormone- like to
activate other cells, inferring that it is involved in intracellular signaling.
It is similar to other cytokines, but most similar to IL 6 and ciliary neuroptic factor receptor (CNER).
![Page 10: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/10.jpg)
IL 12 Information
IL 12 is a complex protein to separate for the genes that codes for its two subunits
For Mice: • alpha subunit found on chromosome 3• beta subunit found on chromosome 11
For Humans:• alpha subunit found on chromosome 3• beta subunit found on chromosome 5
![Page 11: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/11.jpg)
![Page 12: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/12.jpg)
http://www.rcsb.org/pdb/cgi/explore.cgi?job=graphics&pdbId=1F45&page=0&pid=241861012580580
3d Structure
![Page 13: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/13.jpg)
Mutant Versions of IL 12
Alpha subunit p35 1026 bp in length 8 exons, 7 introns 3 SNPs
• @ 634 bp A/G• @ 799 bp T/C• @ 807 bp T/C
Beta subunit p40 2318 bp in length 8 exons, 7 introns 1 SNP @ 1188 bp variation between A &
![Page 14: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/14.jpg)
IL 12 Studied in Many Organisms
Humans, mouse, horse, dog, sheep, cows, pigs, cat, woodchuck, red deer, and sooty mangabey and rhesus macaque(primates)
There is a substantial interest that exists for the study of IL12, but it will take several years for any therapy to become standard.
![Page 15: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/15.jpg)
Comparison of Mouse and Human protein sequences
MCPQKLTISWFAIVLLVSPLMAMWELEKDVYVVEVDWTPDAPGETVNLTCDTPEEDDITW 60MC Q+L ISWF++V L SPL+A+WEL+KDVYVVE+DW PDAPGE V LTCDTPEED ITWMCHQQLVISWFSLVFLASPLVAIWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITW 60
TSDQRHGVIGSGKTLTITVKEFLDAGQYTCHKGGETLSHSHLLLHKKENGIWSTEILKNF 120T DQ V+GSGKTLTI VKEF DAGQYTCHKGGE LSHS LLLHKKE+GIWST+ILK+ TLDQSSEVLGSGKTLTIQVKEFGDAGQYTCHKGGEVLSHSLLLLHKKEDGIWSTDILKDQ 120
---KNKTFLKCEAPNYSGRFTCSWLVQRNMDLKFNIKSSSSSPDSRAVTCGMASLSAEKV 177 KNKTFL+CEA NYSGRFTC WL + DL F++KSS S D + VTCG A+LSAE+VKEPKNKTFLRCEAKNYSGRFTCWWLTTISTDLTFSVKSSRGSSDPQGVTCGAATLSAERV 180
TLDQRDYEKYSVSCQEDVTCPTAEETLPIELALEARQQNKYENYSTSFFIRDIIKPDPPK 237 D ++YE YSV CQED CP AEE+LPIE+ ++A + KYENY++SFFIRDIIKPDPPKRGDNKEYE-YSVECQEDSACPAAEESLPIEVMVDAVHKLKYENYTSSFFIRDIIKPDPPK 239
NLQMKPLKNS-QVEVSWEYPDSWSTPHSYFSLKFFVRIQRKKEKMKETEEGCNQKGAFLV 296NLQ+KPLKNS QVEVSWEYPD+WSTPHSYFSL F V++Q K ++ K K NLQLKPLKNSRQVEVSWEYPDTWSTPHSYFSLTFCVQVQGKSKREK--------KDRVFT 291
EKTSTEVQC-KGGNVCVQAQDRYYNSSCSKWACVPC 331+KTS V C K ++ V+AQDRYY+SS S+WA VPCDKTSATVICRKNASISVRAQDRYYSSSWSEWASVPC 327
![Page 16: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/16.jpg)
Homology Between Mouse and Human
There is a 70% homology between the human and mouse p40 (beta chain) and 60% homology between the p35 chains of IL 12.
Human IL 12 is inactive on mouse cells, mouse IL 12 is active on human cells.
![Page 17: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/17.jpg)
The conserved regions on the alignment are color coded in light blue, the regions of non-conserved regions are coded in white, and the dark blue regions are all the regions where there is an exact match.
![Page 18: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/18.jpg)
Phylogenetic Trees
Shows all species being in common, all are vertebrates and mammals.
Rooted tree shows humans being closely related to macmu and certo, and that the human and mouse diverged from the same species.
Unrooted tree illustrates same information.
![Page 19: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/19.jpg)
![Page 20: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/20.jpg)
Grease Analysis
IL 12 appears to be mostly hydrophilic, with a small hydrophobic region
![Page 21: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/21.jpg)
Acknowledgments Tools used in biology workbench
• Ndjinn-for database searches• ClustalW-alignment of the protein sequences• Drawtree-unrooted phylogenetic tree• Drawgram-rooted phylogenetic tree• BlastN-compare nucleotide sequence to databases• DDB(protein databank)-viewing of structures• Non-Redundant Protein Databaes• BlastP-compare protein sequence to database• Protdist-comparing similarities of proteins• Texshade-graphical comparison of alignment• Boxshade
![Page 22: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/22.jpg)
Acknowledgments Journal of Medical Virology 60:264-268 (2000) Clinical Immunology. Volume 98, Issue 1. January 2001,
pages 119-124. Journal of Clinical Investigation. Volume 108, Issue 12.
December 2001, pages 1749-1758. American Journal of Human Genetics. Volume 67, Issue
1. July 2000, pages 67-81. International Immunology. Volume 13, Issue 5. May
2001, pages 685-694. Journal of Immunology. Volume 166, Issue 6. March
2001, pages 3749-3756.
![Page 23: Analysis of Interleukin 12](https://reader036.vdocuments.net/reader036/viewer/2022081502/56815c21550346895dc9f7a3/html5/thumbnails/23.jpg)
The End